DenerveX System Reimbursement Coding Renewed in Germany

The German reimbursement authority renewed payment coding for Medovex's DenerveX™ technology for the treatment of the facet joint syndrome for 2017.

While DenerveX is not yet CE-Marked or FDA-cleared, leadership expects that the renewal will be a significant driver for European launch preparation. The...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us